Suppr超能文献

一期法因子VIII测定

One-Stage Factor VIII Assays.

作者信息

Duncan Elizabeth, Rodgers Susan

机构信息

Division of Haematology, SA Pathology, Frome Rd, Adelaide, SA, 5000, Australia.

出版信息

Methods Mol Biol. 2017;1646:247-263. doi: 10.1007/978-1-4939-7196-1_20.

Abstract

Coagulation factor assays using one-stage methodology are widely used to measure factor levels for the purpose of detecting a deficiency, or to monitor replacement therapy. In this chapter, we focus on a method to measure Factor VIII coagulant activity (FVIII:C) by the one-stage assay (FVIII:C-1), with extra information provided to also allow this method to apply to Factor IX (FIX), Factor XI (FXI), and Factor XII (FXII). From the perspective of laboratory testing, these factors are components of the "intrinsic" coagulation pathway and are all measured in test systems based on the correction of the Activated Partial Thromboplastin Time (APTT). Factor activity is assessed by measuring the ability of an unknown sample to correct the prolonged APTT of factor-deficient plasma (deficient in the factor of interest), relative to the effect of a known calibrator. These assays are used for the diagnosis of the many causes of reduced factor levels, including those causing a prolonged APTT. It is important for laboratory staff to understand the impact of method variations, limitations, and result interpretation and these aspects are also discussed.

摘要

采用单步法的凝血因子检测广泛用于测定因子水平,以检测缺乏情况或监测替代治疗。在本章中,我们重点介绍一种通过单步法(FVIII:C-1)测量凝血因子VIII促凝活性(FVIII:C)的方法,并提供额外信息以使该方法也适用于凝血因子IX(FIX)、凝血因子XI(FXI)和凝血因子XII(FXII)。从实验室检测的角度来看,这些因子是“内源性”凝血途径的组成部分,并且都是在基于活化部分凝血活酶时间(APTT)校正的检测系统中进行测量。通过测量未知样品相对于已知校准物的作用来校正因子缺乏血浆(缺乏目标因子)延长的APTT的能力,来评估因子活性。这些检测用于诊断多种导致因子水平降低的原因,包括那些导致APTT延长的原因。实验室工作人员了解方法差异、局限性和结果解读的影响非常重要,本章也将讨论这些方面。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验